Also known as: Altace; Tritace; Ramace
Ramipril is a pharmaceutical-grade active ingredient classified as an ACE Inhibitor Antihypertensive. Mediocon Inc supplies high-purity Ramipril API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.
Ramipril is a prodrug ACE inhibitor converted in vivo to ramiprilat, its active metabolite. It is used in the treatment of hypertension, heart failure, diabetic nephropathy, and for the prevention of myocardial infarction, stroke, and cardiovascular death in high-risk patients. Ramipril has demonstrated significant cardiovascular protective effects in major clinical trials.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Ramipril (CAS 87333-19-5) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Ramipril is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance